* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download The types of muscular dystrophy
X-inactivation wikipedia , lookup
Fetal origins hypothesis wikipedia , lookup
Ridge (biology) wikipedia , lookup
Gene nomenclature wikipedia , lookup
Cancer epigenetics wikipedia , lookup
Metagenomics wikipedia , lookup
Biology and consumer behaviour wikipedia , lookup
Gene desert wikipedia , lookup
Genomic imprinting wikipedia , lookup
Human genome wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Saethre–Chotzen syndrome wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Gene therapy wikipedia , lookup
Non-coding DNA wikipedia , lookup
Bisulfite sequencing wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Oncogenomics wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Gene expression programming wikipedia , lookup
History of genetic engineering wikipedia , lookup
Genome (book) wikipedia , lookup
Genome evolution wikipedia , lookup
SNP genotyping wikipedia , lookup
Microsatellite wikipedia , lookup
Gene expression profiling wikipedia , lookup
Helitron (biology) wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Microevolution wikipedia , lookup
Point mutation wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Designer baby wikipedia , lookup
Molecular Inversion Probe wikipedia , lookup
Muscular dystrophy Dr. Derakhshandeh 1 Muscular dystrophy (MD) a group of rare inherited muscle diseases muscle fibers are unusually susceptible to damage Muscles, primarily voluntary muscles, become progressively weaker In some types of muscular dystrophy, heart muscles, other involuntary muscles and other organs are affected 2 voluntary & in voluntary muscles 3 Duchenne's muscular dystrophy (Xp21.2) The types of muscular dystrophy: a genetic deficiency of the protein dystrophin : dystrophinopathies Duchenne's muscular dystrophy : the most severe form of dystrophinopathy. It occurs mostly: in young boys 4 Dystrophin a large (427 kD) cytoskeletal protein structure with an actin-binding domain at the amino terminus (N) The carboxy-terminal domains associate with a large transmembrane complex of glycoproteins directly bind with elements of the extracellular Dystrophin: likely plays a critical role in establishing connections between the internal, actin-based cytoskeleton and the external basement membrane Its absence may lead to increased membrane fragility 5 Dystrophin 6 Duchenne's muscular dystrophy Difficulty getting up from a lying or sitting position Weakness in lower leg muscles, resulting in difficulty running and jumping Waddling gait Mild mental retardation, in some cases 7 Waddling gait 8 In the late stages of muscular dystrophy, fat and connective tissue often replace muscle fibers. 9 10 DMD 11 Orthopaedic management of patients with Duchenne's muscular dystrophy 12 Duchenne's muscular dystrophy X-linked inheritance Prevalence 0.003-0.05/1,000 total Signs and symptoms of Duchenne's usually appear between the ages of 2 and 5 It first affects the muscles of the pelvis, upper arms and upper legs. By late childhood, most children with this form of muscular dystrophy are unable to walk. 13 Most die by their late teens or early 20s, often from pneumonia, respiratory muscle weakness or cardiac complications. Some people with Duchenne's MD may exhibit curvature of their spine (scoliosis). 14 Becker's muscular dystrophy This type of muscular dystrophy is a milder form of dystrophinopathy. It generally affects older boys and young men, and progresses more slowly, usually over several decades. Signs and symptoms of Becker's MD are similar to those of Duchenne's. The onset of the signs and symptoms is generally later, from age 2 to 16. 15 Multiplex PCR images Iranian J Publ Health, Vol. 32, No. 3, pp.47-53, 2003 S Kheradmand kia , DD Farhud , S Zeinali , AR Mowjoodi, H Najmabadi , F Pourfarzad, P Derakhshandeh-Peykar , 16 -/- +/+ -/+ +/y -/+ +/y -/- +/+ -/+ -/y +/+ +/y Iranian J Publ Health, Vol. 32, No. 3, pp.47-53, 2003 17 Iranian J Publ Health, Vol. 32, No. 3, pp.47-53, 2003 18 19 MLPA Multiplex Ligation-dependent Probe Amplification 20 MLPA 21 MLPA analysis of the human DMDgene in a normal male 22 Agarose-gel analysis of DMD deletion patient 23 The MLPA reaction & five major steps 1) DNA denaturation and hybridisation of MLPA probes 2) ligation reaction 3) PCR reaction 4) separation of amplification products by electrophoresis 5) data analysis 24 The MLPA reaction I first step: the DNA is denatured and incubated overnight with a mixture of MLPA probes MLPA probes consist of two separate oligonucleotides, each containing one of the PCR primer sequences The two probe oligonucleotides hybridize to immediately adjacent target sequences Only when the two probe oligonucleotides are both hybridised to their adjacent targets can they be ligated during the ligation reaction only ligated probes will be exponentially amplified during the subsequent PCR reaction 25 The MLPA reaction II the number of probe ligation products is a measure for the number of target sequences in the sample The amplification products are separated using capillary electrophoresis Probe oligonucleotides that are not ligated only contain one primer sequence. As a consequence, they cannot be amplified exponentially and will not generate a signal. The removal of unbound probes is therefore unnecessary in MLPA and makes the MLPA method easy to perform. 26 Advantages of MLPA methods which were primarily developed for detecting point mutations, such as sequencing and DHPLC (denaturing high-performance liquid chromatography), generally fail to detect copy numbers changes Southern blot analysis, will not always detect small deletions and is not ideal as a routine technique comparing MLPA to FISH, MLPA not only has the advantage of being a multiplex technique, but also one in which very small (50-70 nt) sequences are targeted Moreover, MLPA can be used on purified DNA The over 300 probe sets now available are dedicated to applications ranging from the relatively common (Duchenne, DiGeorge syndrome, SMA) 27 MAPH Multiplex Amplifiable Probe Hybridisation 28 MAPH Detection of deletions/duplication mutations in Duchenne Muscular Dystrophy using: MAPH 29 MAPH Although ~95% of deletions can be detected in males using multiplex PCR other methods must be used to determine duplications, as well as the carrier status of females The most commonly applied methods are quantitative multiplex PCR and quantitative Southern blotting 30 MAPH Using high-quality Southern blots it is possible to perform a quantitative analysis and detect duplications this technique is time consuming it is difficult to exactly determine the duplication it can be difficult to detect duplications in females and triplications will be missed Armour et al (Nucl.Acids Res. 2000) 31 system for analyzing all 79 exons of the DMD gene for deletions and duplications MAPH is based on a quantitative PCR of short DNA probes recovered after hybridization to immobilized genomic DNA 32 33 1 ug of denatured genomic DNA is spotted on a small nylon filter hybridized overnight in a solution containing one of the probe mixes Following stringent washing the next day the filter is placed in a PCR tube and a short PCR reaction is performed This releases the specifically-bound probes into the solution An aliquot of this is transferred to a second, quantitative PCR reaction 34 alterations can be examined by using a set of short probes (140-600 bp) After washing and PCR the differently sized products resolved and quantified measured The amount of probe amplified depends on the number of hybridising targets and therefore on the copy number of the corresponding locus in the test DNA 35 36 MAPH dystrophin probe sets A/B: The two probes sets encompassing all exons in normal individuals 37 A relative comparison is made between the band intensities or peak heights 38 39 Outline of the MAPH technique 40 A: a female deleted for exons 49 and 51 B: a control female C: a female duplicated for the exons 49 and 51 D: a male deleted for exons 49 and 51 41 Analysis of exon products on a micro-array PCR-fragments containing DMD exons are spotted in triplicate on each array top left exons 1-24 bottom left exons 49-72 top right exons 25-48 bottom right exons 73-79 42 Applications areas such as cancer risk (BRCA1 and HNPCC) learning disability (US: "mental retardation") muscular dystrophy (DMD/BMD) neuromuscular disorders (SMA) 43 db-Thalassemia Disorders of Hemoglobin Dr. Pupak Derakhshandeh 44 Understanding globin regulation in β-thalassemia: it’s as simple as α, β, γ, δ Arthur Bank The Journal of Clinical Investigation http://www.jci.org Volume 115 Number 6 June 2005 45 Thehuman best characterized The globin loci in the human genome at the gene and protein levels The β–locus control region (β-LCR): A dominant control region located upstream of the globin structural genes a strong enhancer of the expression of the downstream 46 . The human globin locus and their role in β-thalassemia (A) The β-LCR and structural genes (ε, Gγ, Aγ, δ, and β) in the β-globin locus on chromosome 11 47 The major genes expressed throughout fetal life The 2 α-globin gene γ-globin genes, Gand A 48 49 (B) The α-globin locus is shown with the ζ- and 2 αglobin genes on chromosome 16 50 b-Globin gene expression between cis-acting sequences: The β-LCR trans-acting factors: including transcription factors 51 C) In early fetal life, the α- and γ-globin chains combine to form HbF (α2γ2), the main β-globin–like globin during the remainder of fetal life and early postnatal life Severe anemia results >> 52 In fetal life 53 In Adult life 54 55 The current therapy for β-thalassemia Blood transfusions + iron Chelation Decreasing and/or BM α-globin accumulation reactivating γ-globin production transplantation 56 Decreasing excess α-globin accumulation Unequal crossing over in meiosis: deletion of the α-globin gene reduces α-globin synthesis in patients Homozygous for β-thalassemia (Major) + decreases the α-globin excess >> decreased severity of anemia 57 Increasing human γ-globin expression reduce anemia and cure human βthalassemia increase in human γ-globin gene expression >> restoration of HbF Point mutations in the γ-globin gene promoter: increase γ-globin expression, but not by agreat amount 58 Hereditary persistence of fetal hemoglobin (HPFH) -globin genes at the same level in adult life as in fetal life express Some HPFH homozygotes have only HbF (a2g2) and no anemia! 59 Doesn't cause any health problem HPFH / bThalassemia (no problem) HPFH / HPFH 60 HPFH as a δβ-globin Disease Large deletions at the β-globin locus from the region close to the human Aγ gene to well downstream of the human β-globin gene and including deletion of the structural δ- and β-globin genes 61 HPFH Heterozygotes: a normal level of HbA2 even higher levels of HbF (15 to 30 %) Homozygotes: clinically normal albeit with reduced MCV and MCH Compound heterozygotes with b thalassemia: clinically very mild 62 63 HPFH group of disorders characterized by a decreased or absent: b-chain synthesis a variable compensatory increase in g-chain synthesis 64 Intergenic γδ sequences: γ-globin gene regulation Corfu: homozygous for the Corfu deletion a deletion of 7.2 kb DNA upstream of the δ-globin homozygotes were shown to possess 88%-90% HbF only mild anemia Did not require blood transfusion 65 Corfu deletion 66 Molecular diagnosis of haemoglobin disorders Clin. Lab. Haem. 2004, 26, 159–176 B. E. CLARK, S. L. THEIN Department of Haematological Medicine, King’s College Hospital and GKT School of Medicine, Denmark Hill, London, UK 67 The beta locus on chromosome 11 p15.4 with the e,Gg and Ag, d and b genes, arranged in the order of their developmental expression 68 Gap-PCR db-thalassaemias: the common HPFH Hb Lepore -a Thalassemia, … 69 Gap-PCR for the African HPFH-2 deletion N D N N D N N D D D N D D N N 918 639 bp 70 71 Homozygosity for nondeletion db0 thalassemia resulting in a silent clinical phenotype BLOOD, 1 SEPTEMBER 2002 VOLUME 100, NUMBER 5 Renzo Galanello, Susanna Barella, Stefania Satta, Liliana Maccioni, Carlo Pintor, and Antonio Cao 72 Nondeletion Sardinian db0 thalassemia a homozygous state for nondeletion Sardinian db0 thalassemia a symptomless clinical phenotype with pattern (Hb F: 99.8% and Hb A2: 0.2%) 73 The molecular defects the presence of 2 nucleotide substitutions: -196C>T in the promoter of the Ag-globin gene 39C>T nonsense mutation in b-globin gene * * 74 75 The absence of typical thalassemia clinical findings high Hb F output: which compensated for the absence of chains The near absence of Hb A2: alterations in the globin gene transcriptional : Activation of g-globin genes and suppression of d-globin genes or preferential survival of red blood cells with the highest Hb F and low Hb A2 level 76 The absence of typical thalassemia clinical findings imbalance in the ratio of a to g similar to that in heterozygous thalassemia explains the reduction in MCV mean corpuscular Hb The 77 Patient with nondeletion homozygous db0 thalassemia Had almost no HbA2 (0.3%) the suppressive effect of the in cis Ag -196CT mutation This suppressive in cis effect has already been reported for similar mutations, such as the 202 Gg HPFH 78